Interestingly, we have also recently reported that these miRNAs display reduced expression during BC progression by promoter methylation and/or EZH2 expression [119], suggesting that this repression could be mediated by EZH2-DNMTs collaborative activity. Here, EZH2 is linked to breast cancer.